Tandem Diabetes Care Files 2024 10-K
Ticker: TNDM · Form: 10-K · Filed: 2025-02-26T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, medical-devices
TL;DR
Tandem Diabetes Care dropped its 2024 10-K. Check financials and future outlook.
AI Summary
Tandem Diabetes Care Inc. filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in San Diego, CA, operates in the surgical and medical instruments sector. This filing provides a comprehensive overview of its financial performance and business operations for the year.
Why It Matters
This 10-K filing is crucial for investors and stakeholders to understand Tandem Diabetes Care's financial health, strategic direction, and potential risks for the 2024 fiscal year.
Risk Assessment
Risk Level: medium — The filing is a standard annual report, but the medical device industry can be subject to regulatory changes and competitive pressures.
Key Players & Entities
- TANDEM DIABETES CARE INC (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-26 (date) — Filing date
- San Diego, CA (location) — Company headquarters
- 3841 (industry_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What were Tandem Diabetes Care's total revenues for the fiscal year ended December 31, 2024?
The filing indicates the fiscal year ended December 31, 2024, but specific revenue figures are not detailed in the provided header information.
What is Tandem Diabetes Care's primary business segment?
Tandem Diabetes Care operates within the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on February 26, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 12400 High Bluff Drive, San Diego, CA 92130.
What is the SEC file number for Tandem Diabetes Care?
The SEC file number for Tandem Diabetes Care is 001-36189.
From the Filing
0001438133-25-000036.txt : 20250226 0001438133-25-000036.hdr.sgml : 20250226 20250226160922 ACCESSION NUMBER: 0001438133-25-000036 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 111 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250226 DATE AS OF CHANGE: 20250226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 25670072 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 10-K 1 tndm-20241231.htm 10-K tndm-20241231 false 2024 FY 0001438133 P3Y 0.0289361 0.0088836 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft tndm:extension tndm:trading_day tndm:purchase_period tndm:segment tndm:market iso4217:CHF 0001438133 2024-01-01 2024-12-31 0001438133 2024-06-30 0001438133 2025-02-21 0001438133 2024-12-31 0001438133 2023-12-31 0001438133 2023-01-01 2023-12-31 0001438133 2022-01-01 2022-12-31 0001438133 us-gaap:CommonStockMember 2021-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001438133 us-gaap:RetainedEarningsMember 2021-12-31 0001438133 2021-12-31 0001438133 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001438133 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001438133 us-gaap:CommonStockMember 2022-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001438133 us-gaap:RetainedEarningsMember 2022-12-31 0001438133 2022-12-31 0001438133 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001438133 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001438133 us-gaap:CommonStockMember 2023-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001438133 us-gaap:RetainedEarningsMember 2023-12-31 0001438133 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001438133 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001438133 us-gaap:CommonStockMember 2024-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001438133 us-gaap:RetainedEarningsMember 2024-12-31 0001438133 tndm:InsulinPumpMember srt:MinimumMember 2024-01-01 2024-12-31 0001438133 us-gaap:CustomerConcentrationRiskMember tndm:DistributorAMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-12-31 0001438133 us-gaap:CustomerConcentrationRiskMember tndm:DistributorAMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-12-31 0001438133 us-gaap:CustomerConcentrationRiskMember tndm:DistributorAMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-12-31 0001438133 us-gaap:CustomerConcentrationRiskMember tndm:DistributorAMember us-gaap:AccountsReceivableMember 2024-01-01 2024-12-31 0001438133 us-gaap:CustomerConcentrationRiskMember tndm:DistributorAMember us-gaap:AccountsReceivableMember 2023-01-01 2023-12-31 0001438133 us-gaap:CustomerConcentrationRiskMember tndm:DistributorBMember us-gaap:AccountsReceivableMember 2023-01-01 2023-12-31 0001438133